Literature DB >> 3787506

Tissue inhibitor of metalloproteinases and collagenase inhibitory activity in lung secretions from patients with chronic obstructive bronchitis: effect of corticosteroid treatment.

D Burnett, J J Reynolds, R V Ward, S C Afford, R A Stockley.   

Abstract

Tissue inhibitor of metalloproteinases (TIMP) and collagenase inhibitory activity were measured in the sputum from nine subjects with chronic bronchitis before and five days after treatment with corticosteroid (oral prednisolone, 40 mg daily). The mean sputum TIMP concentrations for eight of the nine subjects increased from 3.1 (SD 0.87) micrograms/ml to 5.8 (1.9) micrograms/ml (2p less than 0.005). Similarly, the mean collagenase inhibitory activity in the sputum of eight of the nine subjects increased from 1.53 (1.1) U/ml to 2.69 (0.92) U/ml (2p less than 0.05). The TIMP concentrations in sputum exceeded the collagenase inhibitory activity, suggesting that a proportion of the TIMP was inactive. TIMP inactivity was not due to prior complexing with enzyme since the molecular weight of sputum TIMP (27,500) was similar to that described for the purified protein (28,000-28,500). Preliminary studies showed the presence of TIMP in bronchoalveolar lavage samples (range of six specimens 0.45 ng/ml-2.1 micrograms/ml, median 53 ng/ml). Collagenase inhibitory activity was detected in only two of these six lavage samples, suggesting that the TIMP was totally inactive in the other four samples. The significance of the metalloproteinase-inhibitor balance in the pathogenesis of chronic lung disease requires further study.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3787506      PMCID: PMC460466          DOI: 10.1136/thx.41.10.740

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  23 in total

1.  Collagenase in the lower respiratory tract of patients with idiopathic pulmonary fibrosis.

Authors:  J E Gadek; J A Kelman; G Fells; S E Weinberger; A L Horwitz; H Y Reynolds; J D Fulmer; R G Crystal
Journal:  N Engl J Med       Date:  1979-10-04       Impact factor: 91.245

2.  The induction of pulmonary emphysema with human leukocyte elastase.

Authors:  R M Senior; H Tegner; C Kuhn; K Ohlsson; B C Starcher; J A Pierce
Journal:  Am Rev Respir Dis       Date:  1977-09

3.  The oxidative inactivation of human alpha-1-proteinase inhibitor. Further evidence for methionine at the reactive center.

Authors:  D Johnson; J Travis
Journal:  J Biol Chem       Date:  1979-05-25       Impact factor: 5.157

4.  Studies in alpha 1-antitrypsin deficiency.

Authors:  S Eriksson
Journal:  Acta Med Scand Suppl       Date:  1965

5.  Alpha,-antitrypsin and leukocyte elastase in infected and noninfected sputum.

Authors:  R A Stockley; D Burnett
Journal:  Am Rev Respir Dis       Date:  1979-11

6.  Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema.

Authors:  J E Gadek; G A Fells; R L Zimmerman; S I Rennard; R G Crystal
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

7.  Messenger function of prostaglandins in cell to cell interactions and control of proteinase activity in the rheumatoid joint.

Authors:  M K McGuire; J E Meats; N M Ebsworth; G Murphy; J J Reynolds; R G Russell
Journal:  Int J Immunopharmacol       Date:  1982

8.  Serum and sputum alpha 2 macroglobulin in patients with chronic obstructive airways disease.

Authors:  D Burnett; R A Stockley
Journal:  Thorax       Date:  1981-07       Impact factor: 9.139

9.  An inhibitor of collagenase from human amniotic fluid. Purification, characterization and action on metalloproteinases.

Authors:  G Murphy; T E Cawston; J J Reynolds
Journal:  Biochem J       Date:  1981-04-01       Impact factor: 3.857

10.  Neutral metalloendopeptidase in human lung tissue and cultured cells.

Authors:  A R Johnson; J Ashton; W W Schulz; E G Erdös
Journal:  Am Rev Respir Dis       Date:  1985-09
View more
  4 in total

Review 1.  alpha-1-Antitrypsin and the pathogenesis of emphysema.

Authors:  R A Stockley
Journal:  Lung       Date:  1987       Impact factor: 2.584

2.  Collagenase and fibronectin in bronchoalveolar lavage fluid in patients with sarcoidosis.

Authors:  C O'Connor; C Odlum; A Van Breda; C Power; M X Fitzgerald
Journal:  Thorax       Date:  1988-05       Impact factor: 9.139

3.  Antitumor activity of liposomal prednisolone phosphate depends on the presence of functional tumor-associated macrophages in tumor tissue.

Authors:  Manuela Banciu; Josbert M Metselaar; Raymond M Schiffelers; Gert Storm
Journal:  Neoplasia       Date:  2008-02       Impact factor: 5.715

Review 4.  Biomarkers in chronic obstructive pulmonary disease: confusing or useful?

Authors:  Robert A Stockley
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-02-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.